Plant Secondary Metabolites in Cancer Chemotherapy: Where are We?

E-ISSN： 1873-4316|13|5|632-650

ISSN： 1389-2010

Source： Current Pharmaceutical Biotechnology, Vol.13, Iss.5, 2012-04, pp. : 632-650

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Intraperitoneal Chemotherapy for Ovarian Cancer: Where Are We Now?

By Singhal Pankaj Lele Shashikant

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 4, Iss. 9, 2006-10 ,pp. : 941-946

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite

Biotechnologically Produced Secondary Plant Metabolites for Cancer Treatment and Prevention

Current Pharmaceutical Biotechnology, Vol. 13, Iss. 1, 2012-01 ,pp. : 265-275

Bentham Science Publishers

Access to resources Recommend Favorite

High-Dose Chemotherapy and Stem Cell Support for Breast Cancer: Where Are We Now?

By Gerrero R.M. Stein S. Stadtmauer E.A.

Drugs & Aging, Vol. 19, Iss. 7, 2002-01 ,pp. : 475-485

Adis International

Access to resources Recommend Favorite

Survey of Secondary Plant Metabolites with Cardiovascular Activity

By Ghisalberti Emilio L. Pennacchio Marcello Alexander Elizabeth

Pharmaceutical Biology (Formerly International Journal of Pharmacognosy), Vol. 36, Iss. 4, 1998-10 ,pp. : 237-279

Informa Healthcare

Access to resources Recommend Favorite

Thioredoxin System Modulation by Plant and Fungal Secondary Metabolites

Current Medicinal Chemistry, Vol. 17, Iss. 5, 2010-02 ,pp. : 479-494

Bentham Science Publishers

Access to resources Recommend Favorite